Vontobel Holding Ltd. Purchases 341 Shares of Veeva Systems Inc. (NYSE:VEEV)

Vontobel Holding Ltd. boosted its position in Veeva Systems Inc. (NYSE:VEEV) by 1.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 28,760 shares of the technology company’s stock after acquiring an additional 341 shares during the period. Vontobel Holding Ltd.’s holdings in Veeva Systems were worth $5,537,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the stock. UMB Bank n.a. boosted its stake in shares of Veeva Systems by 2.5% during the 3rd quarter. UMB Bank n.a. now owns 2,103 shares of the technology company’s stock valued at $428,000 after purchasing an additional 51 shares in the last quarter. NewEdge Wealth LLC boosted its stake in shares of Veeva Systems by 0.6% during the 3rd quarter. NewEdge Wealth LLC now owns 10,059 shares of the technology company’s stock valued at $2,047,000 after purchasing an additional 60 shares in the last quarter. Personal CFO Solutions LLC boosted its stake in shares of Veeva Systems by 5.9% during the 3rd quarter. Personal CFO Solutions LLC now owns 1,091 shares of the technology company’s stock valued at $222,000 after purchasing an additional 61 shares in the last quarter. Penserra Capital Management LLC boosted its stake in shares of Veeva Systems by 9.3% during the 4th quarter. Penserra Capital Management LLC now owns 729 shares of the technology company’s stock valued at $117,000 after purchasing an additional 62 shares in the last quarter. Finally, Toroso Investments LLC boosted its stake in Veeva Systems by 4.9% during the third quarter. Toroso Investments LLC now owns 1,318 shares of the technology company’s stock worth $217,000 after acquiring an additional 62 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Activity at Veeva Systems

In related news, Director Timothy S. Cabral sold 15,000 shares of Veeva Systems stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $226.04, for a total value of $3,390,600.00. Following the sale, the director now owns 23,391 shares of the company’s stock, valued at approximately $5,287,301.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Jonathan Faddis sold 3,598 shares of Veeva Systems stock in a transaction on Monday, April 15th. The shares were sold at an average price of $207.42, for a total value of $746,297.16. Following the sale, the senior vice president now owns 10,668 shares of the company’s stock, valued at approximately $2,212,756.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy S. Cabral sold 15,000 shares of Veeva Systems stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $226.04, for a total transaction of $3,390,600.00. Following the completion of the sale, the director now directly owns 23,391 shares in the company, valued at approximately $5,287,301.64. The disclosure for this sale can be found here. In the last quarter, insiders have sold 19,836 shares of company stock valued at $4,396,902. 10.98% of the stock is owned by company insiders.

Veeva Systems Price Performance

NYSE:VEEV opened at $199.18 on Thursday. The firm has a market cap of $32.13 billion, a price-to-earnings ratio of 61.86, a price-to-earnings-growth ratio of 2.02 and a beta of 0.74. The company has a 50 day moving average price of $221.86 and a 200-day moving average price of $202.84. Veeva Systems Inc. has a 1-year low of $160.21 and a 1-year high of $236.90.

Veeva Systems (NYSE:VEEV) last posted its earnings results on Thursday, February 29th. The technology company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.11. The firm had revenue of $630.62 million during the quarter, compared to analyst estimates of $620.75 million. Veeva Systems had a net margin of 22.24% and a return on equity of 11.26%. On average, sell-side analysts anticipate that Veeva Systems Inc. will post 4.11 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Oppenheimer reissued an “outperform” rating and set a $225.00 price objective on shares of Veeva Systems in a research note on Thursday, February 22nd. Truist Financial boosted their price objective on shares of Veeva Systems from $187.00 to $203.00 and gave the company a “hold” rating in a report on Friday, March 1st. Jefferies Financial Group boosted their price objective on shares of Veeva Systems from $225.00 to $270.00 and gave the company a “buy” rating in a report on Monday, March 4th. Citigroup upped their target price on shares of Veeva Systems from $240.00 to $264.00 and gave the company a “buy” rating in a report on Friday, March 1st. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $260.00 target price on shares of Veeva Systems in a report on Tuesday, April 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $234.90.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.